tiprankstipranks
Trending News
More News >
JMS Co., Ltd. (JP:7702)
:7702
Japanese Market
Advertisement

JMS Co., Ltd. (7702) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7702

JMS Co., Ltd.

(7702)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
¥446.00
▲(2.06% Upside)
The overall stock score of 54 reflects JMS Co., Ltd.'s stable financial structure and revenue growth, but is significantly impacted by weak profitability and negative cash flow. Technical indicators suggest bearish momentum, and valuation concerns arise from a negative P/E ratio, though the dividend yield offers some compensation.

JMS Co., Ltd. (7702) vs. iShares MSCI Japan ETF (EWJ)

JMS Co., Ltd. Business Overview & Revenue Model

Company DescriptionJMS Co., Ltd. (7702) is a prominent company based in Japan, primarily engaged in the manufacturing and distribution of precision instruments and components. The company operates in various sectors, including medical devices, industrial equipment, and environmental measurement systems. JMS Co., Ltd. is known for its innovative products, including high-performance sensors and analyzers that cater to a wide range of industries, ensuring quality and accuracy in measurements.
How the Company Makes MoneyJMS Co., Ltd. generates revenue through multiple streams, primarily by selling its precision instruments and components directly to various sectors such as healthcare, manufacturing, and environmental services. The company's revenue model includes direct sales, partnerships with distributors, and long-term contracts with industrial clients. Additionally, JMS Co., Ltd. benefits from research and development collaborations with other companies and institutions, which can lead to new product innovations and technologies that enhance its market offerings. The company also focuses on after-sales services and support, providing maintenance and calibration services that contribute to ongoing revenue. Strategic partnerships with key industry players help JMS expand its market reach and improve its product portfolio, further driving its earnings.

JMS Co., Ltd. Financial Statement Overview

Summary
JMS Co., Ltd. shows revenue growth and improved gross profit margins, but profitability is weak with a low net profit margin and declining ROE. The balance sheet is stable with moderate leverage, but negative free cash flow indicates poor capital expenditure management.
Income Statement
65
Positive
JMS Co., Ltd. has shown steady revenue growth with a 6.8% increase from 2024 to 2025. The gross profit margin improved to 22.8% in 2025 from 21.6% in 2024. However, net profit margin remains weak at 0.13% for 2025, indicating challenges in cost management or pricing strategy. EBITDA margin slightly improved to 6.9%, suggesting operational improvements but net income volatility impacts profitability.
Balance Sheet
70
Positive
The company maintains a solid equity base with an equity ratio of 50.2% in 2025, reflecting a stable financial structure. The debt-to-equity ratio is moderate at 0.60, indicating manageable leverage. However, return on equity dropped from 2.2% in 2023 to 0.22% in 2025, highlighting reduced profitability on shareholders’ investments.
Cash Flow
50
Neutral
Cash flow analysis reveals challenges with negative free cash flow in 2025 at -1.42 billion JPY, down from a positive 498 million JPY in 2024. Operating cash flow to net income ratio is robust at 16.6, suggesting strong cash generation relative to net income, but the negative free cash flow signals a need for better capital expenditure management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue69.12B69.75B65.29B63.74B58.17B57.58B
Gross Profit15.84B15.93B14.09B14.60B14.27B15.10B
EBITDA4.20B4.79B4.08B4.38B4.59B5.64B
Net Income-277.00M89.00M-36.00M281.00M826.00M1.74B
Balance Sheet
Total Assets80.33B81.43B84.71B74.41B71.97B69.08B
Cash, Cash Equivalents and Short-Term Investments6.20B5.51B10.31B6.33B6.81B6.22B
Total Debt23.36B24.55B26.92B19.75B18.71B18.50B
Total Liabilities40.34B40.50B43.96B35.71B34.88B34.09B
Stockholders Equity39.91B40.84B40.57B38.53B36.96B34.84B
Cash Flow
Free Cash Flow0.00-1.42B498.00M-1.07B1.14B481.00M
Operating Cash Flow0.001.47B3.14B2.48B4.40B3.74B
Investing Cash Flow0.00-3.14B-4.24B-3.69B-3.68B-3.25B
Financing Cash Flow0.00-3.19B4.78B525.00M-499.00M-535.00M

JMS Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price437.00
Price Trends
50DMA
440.24
Negative
100DMA
432.07
Positive
200DMA
434.51
Positive
Market Momentum
MACD
-1.94
Positive
RSI
50.72
Neutral
STOCH
63.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7702, the sentiment is Positive. The current price of 437 is below the 20-day moving average (MA) of 437.69, below the 50-day MA of 440.24, and above the 200-day MA of 434.51, indicating a neutral trend. The MACD of -1.94 indicates Positive momentum. The RSI at 50.72 is Neutral, neither overbought nor oversold. The STOCH value of 63.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7702.

JMS Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥5.56B8.351.91%5.45%0.23%
73
Outperform
¥147.83B28.602.60%5.10%-17.80%
68
Neutral
¥69.08B16.742.73%6.82%-1.08%
67
Neutral
¥16.68B14.532.72%2.38%-48.68%
63
Neutral
$112.76B91.801.63%1.67%-0.91%-52.71%
54
Neutral
¥10.70B3.89%3.36%-310.49%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7702
JMS Co., Ltd.
438.00
-23.94
-5.18%
JP:3593
Hogy Medical Co
5,280.00
543.78
11.48%
JP:7730
Mani, Inc.
1,500.50
-180.83
-10.76%
JP:7743
Seed Co., Ltd.
551.00
69.09
14.34%
JP:7979
Shofu Inc.
1,936.00
-252.91
-11.55%
JP:7980
Shigematsu Works Co., Ltd.
786.00
-18.11
-2.25%

JMS Co., Ltd. Corporate Events

JMS Co., Ltd. Faces Financial Challenges Amid Declining Sales
Aug 8, 2025

JMS Co., Ltd. reported a decrease in net sales and operating profit for the first quarter of the fiscal year ending March 2026. The company’s net sales fell by 3.9% compared to the previous year, while it recorded an operating loss of 176 million yen. The comprehensive income also showed a significant decline, and the capital adequacy ratio slightly decreased, indicating financial challenges. Despite these setbacks, the company maintained its dividend forecast, suggesting a commitment to returning value to shareholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 18, 2025